MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
15.62
-1.09 (-6.52%)
At close: Jan 22, 2026, 4:00 PM EST
15.76
+0.14 (0.90%)
Pre-market: Jan 23, 2026, 4:41 AM EST
MLTX Market Cap
MLTX has a market cap or net worth of $1.11 billion as of January 23, 2026. Its market cap has decreased by -65.84% in one year.
Market Cap
1.11B
Enterprise Value
810.10M
1-Year Change
-65.84%
Ranking
Category
Stock Price
$15.62
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.11B, an increase of 30,884.74%. That is a compound annual growth rate of 328.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.11B | 18.51% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.28B |
| Sana Biotechnology | 1.27B |
| Xeris Biopharma Holdings | 1.26B |
| Rapport Therapeutics | 1.26B |
| Capricor Therapeutics | 1.26B |
| Day One Biopharmaceuticals | 1.24B |
| Inventiva | 1.23B |
| Pharming Group | 1.22B |